2023
DOI: 10.1016/j.xpro.2022.101922
|View full text |Cite
|
Sign up to set email alerts
|

Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…A previous study in Rosa26-Cas9 knock-in mouse showed that constitutive SpCas9 expression did not result in any detectable toxicity or morphological abnormalities in multiple organs (including the brain, kidney, liver, spleen, and heart tissue) of this transgenic strain [ 24 ]. Multiple studies have provided evidence of the safety of Cas9 mice by showcasing the utilization of diverse tissues and cells from these murine models [ 34 , 35 , 36 ]. However, long-term SpCas9 expression and its associated toxicity have not been characterized in ocular tissues in these mice, which can be bred for germline transmission of the Cas9 allele.…”
Section: Discussionmentioning
confidence: 99%
“…A previous study in Rosa26-Cas9 knock-in mouse showed that constitutive SpCas9 expression did not result in any detectable toxicity or morphological abnormalities in multiple organs (including the brain, kidney, liver, spleen, and heart tissue) of this transgenic strain [ 24 ]. Multiple studies have provided evidence of the safety of Cas9 mice by showcasing the utilization of diverse tissues and cells from these murine models [ 34 , 35 , 36 ]. However, long-term SpCas9 expression and its associated toxicity have not been characterized in ocular tissues in these mice, which can be bred for germline transmission of the Cas9 allele.…”
Section: Discussionmentioning
confidence: 99%